ResearcherUniversity of MiamiActive in the last 2 years
Mary P Martos
Matched on ORCID iD 0009-0000-7838-2182; OpenAlex author ID A5112598703. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2024: 2 papers · 2025: 2 papers · 2026: 2 papers
Papers 6
- Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18664-0↗
- ASO Visual Abstract: Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18846-w↗
- Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuvant therapy in pancreatic cancer. Co-author DOI 10.1002/cncr.70130↗
- Neighborhood Disadvantage is Associated with Worse Pathologic Response in Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-17024-2↗
- Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected pancreatic cancer: A multi-institutional ana… Co-author DOI 10.1002/jso.27798↗
- Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer. Co-author DOI 10.21037/hbsn-23-668↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Caitlin A. Hester · 6 shared papers, 2024–2026 · strength 1.42
- Paper Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer. DOI 10.1245/s10434-025-18664-0↗
- Paper ASO Visual Abstract: Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cance… DOI 10.1245/s10434-025-18846-w↗
- Paper Neighborhood Disadvantage is Associated with Worse Pathologic Response in Pancreatic Cancer. DOI 10.1245/s10434-025-17024-2↗
- Nipun B. Merchant · 6 shared papers, 2024–2026 · strength 1.42
- Paper Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer. DOI 10.1245/s10434-025-18664-0↗
- Paper ASO Visual Abstract: Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cance… DOI 10.1245/s10434-025-18846-w↗
- Paper Neighborhood Disadvantage is Associated with Worse Pathologic Response in Pancreatic Cancer. DOI 10.1245/s10434-025-17024-2↗
- Erin M. Dickey · 5 shared papers, 2024–2026 · strength 1.16
- Paper Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer. DOI 10.1245/s10434-025-18664-0↗
- Paper ASO Visual Abstract: Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cance… DOI 10.1245/s10434-025-18846-w↗
- Paper Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer. DOI 10.21037/hbsn-23-668↗
- Peter J. Hosein · 4 shared papers, 2024–2026 · strength 1.00
- Paper Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer. DOI 10.1245/s10434-025-18664-0↗
- Paper ASO Visual Abstract: Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cance… DOI 10.1245/s10434-025-18846-w↗
- Paper Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer. DOI 10.21037/hbsn-23-668↗
- Jashodeep Datta · 3 shared papers, 2025–2026 · strength 0.81
- Paper Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer. DOI 10.1245/s10434-025-18664-0↗
- Paper ASO Visual Abstract: Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cance… DOI 10.1245/s10434-025-18846-w↗
- Paper Neighborhood Disadvantage is Associated with Worse Pathologic Response in Pancreatic Cancer. DOI 10.1245/s10434-025-17024-2↗
- Shishir Kumar Maithel · 3 shared papers, 2024–2025 · strength 0.63
- Paper Neighborhood Disadvantage is Associated with Worse Pathologic Response in Pancreatic Cancer. DOI 10.1245/s10434-025-17024-2↗
- Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
- Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
- Jashodeep Datta · 3 shared papers, 2024–2025 · strength 0.60
- Paper Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer. DOI 10.21037/hbsn-23-668↗
- Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
- Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
- Gretel Terrero · 2 shared papers, 2026 · strength 0.56
- Haleh Amirian · 2 shared papers, 2024 · strength 0.39
- David A. Kooby · 2 shared papers, 2024–2025 · strength 0.37
- Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
- Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
- Alexander A. Parikh · 2 shared papers, 2024–2025 · strength 0.37
- Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
- Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
- Daniel Erik Abbott · 2 shared papers, 2024–2025 · strength 0.37
- Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
- Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
- Syed Nabeel Zafar · 2 shared papers, 2024–2025 · strength 0.37
- Paper Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuva… DOI 10.1002/cncr.70130↗
- Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
- Natasha Leigh‐Matijakovich · 1 shared paper, 2025 · strength 0.21
- Syed Ameen Ahmad · 1 shared paper, 2025 · strength 0.21
- Kawther Abdilleh · 1 shared paper, 2025 · strength 0.21
- Gregory C. Wilson · 1 shared paper, 2024 · strength 0.16
- Ifeanyichukwu Chinedu Ogobuiro · 1 shared paper, 2024 · strength 0.16
- Hong Joo Kim · 1 shared paper, 2024 · strength 0.16
- Syed Arif Ahmad · 1 shared paper, 2024 · strength 0.16
- Rebecca Anne Snyder · 1 shared paper, 2024 · strength 0.16
- Chet W. Hammill · 1 shared paper, 2024 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.